Quiero saber acerca de...

38230

Federal Register / Vol. 86, No. 136 / Tuesday, July 20, 2021 / Rules and Regulations
Airspace Designations and Reporting Points, dated July 21, 2020, and effective September 15, 2020, is amended as follows:
Paragraph 6005 Class E Airspace Areas Extending Upward From 700 Feet or More Above the Surface of the Earth.

ANE ME E5 Monhegan Island, ME New Monhegan Island Heliport, ME
Lat. 434552 N, long. 691852 W
That airspace extending upward from 700
feet above the surface of the earth within a 6-mile radius of Monhegan Island Heliport.
Issued in College Park, Georgia, on July 12, 2021.
Andreese C. Davis, Manager, Airspace & Procedures Team South, Eastern Service Center, Air Traffic Organization.
FR Doc. 202115284 Filed 71921; 8:45 am BILLING CODE 491013P

DEPARTMENT OF JUSTICE
Drug Enforcement Administration 21 CFR Part 1305
Docket No. DEA662
RIN 1117AB61

Clarification Regarding the Suppliers DEA Registration Number on the Single-Sheet DEA Form 222
Drug Enforcement Administration, Department of Justice.
ACTION: Direct final rule.
AGENCY:

The Drug Enforcement Administration DEA is issuing this direct final rule to amend DEA
regulations to clarify that either the purchaser or the supplier may enter a suppliers DEA registration number on the Single-Sheet DEA Form 222.
DATES: This direct final rule is effective on October 18, 2021 without further action, unless significant adverse comment is received by August 19, 2021. If the Drug Enforcement Administration DEA receives significant adverse comment, it will publish a withdrawal of the rule in the Federal Register by September 20, 2021.
Electronic comments must be submitted, and written comments must be postmarked, on or before August 19, 2021. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period.
ADDRESSES: To ensure proper handling of comments, please reference Docket
khammond on DSKJM1Z7X2PROD with RULES

SUMMARY:

VerDate Sep<11>2014

15:59 Jul 19, 2021

Jkt 253001

No. DEA662 on all correspondence, including any attachments.
Electronic comments: DEA encourages that all comments be submitted through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to http
www.regulations.gov and follow the online instructions at that site for submitting comments. Upon completion of your submission, you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on Regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.
Paper comments: Paper comments that duplicate an electronic submission are not necessary and are discouraged.
Should you wish to mail a paper comment in lieu of an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152.
FOR FURTHER INFORMATION CONTACT:
Scott A. Brinks, Regulatory Drafting and Policy Support Section, Diversion Control Division, Drug Enforcement Administration; Telephone: 571 776
2265.
SUPPLEMENTARY INFORMATION:
Posting of Public Comments Please note that all comments received are considered part of the public record. They will, unless reasonable cause is given, be made available by the Drug Enforcement Administration DEA for public inspection online at http
www.regulations.gov. Such information includes personal identifying information such as your name, address, etc. voluntarily submitted by the commenter. The Freedom of Information Act applies to all comments received. If you want to submit personal identifying information such as your name, address, etc. as part of your comment, but do not want it to be made publicly available, you must include the phrase PERSONAL IDENTIFYING
INFORMATION in the first paragraph of your comment. You must also place all of the personal identifying information you do not want publicly available in the first paragraph of your comment and identify what information you want redacted.

PO 00000

Frm 00022

Fmt 4700

Sfmt 4700

If you want to submit confidential business information as part of your comment, but do not want it to be made publicly available, you must include the phrase Confidential Business Information in the first paragraph of your comment. You must also prominently identify confidential business information to be redacted within the comment.
Comments containing personal identifying information and confidential business information as directed above will generally be made publicly available in redacted form. If a comment has so much confidential business information or personal identifying information that it cannot be effectively redacted, all or part of that comment may not be made publicly available.
Comments posted to http
www.regulations.gov may include any personal identifying information such as name, address, and phone number included in the text of your electronic submission that is not identified as directed above as confidential.
An electronic copy of this direct final rule is available at http
www.regulations.gov under FDMS
Docket ID: DEA20200036.
Legal Authority and Background The Controlled Substances Act CSA
grants the Attorney General authority to promulgate rules and regulations relating to the registration and control of the manufacture, distribution, and dispensing of controlled substances;
maintenance and submission of records and reports; and for the efficient execution of his statutory functions.1
The CSA further authorizes the Attorney General to promulgate rules and regulations relating to the registration and control of importers and exporters of controlled substances.2 The Attorney General has delegated this authority to the Administrator of DEA.3
The DEA Form 222 is used by DEA
registrants to order schedule I and II
controlled substances. In September 2019, DEA issued a final rule to implement a new single-sheet DEA
Form 222 single-sheet form to replace the three-part carbon copy form triplicate form, and allowed a transition period for use of existing stocks of the triplicate form until October 30, 2021 or earlier if the registrant exhausts its supply.4 Both the single-sheet and triplicate forms require certain information to be completed 1 21

U.S.C. 821, 827, 871b.
U.S.C. 958f.
3 28 CFR 0.100b.
4 New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances DEA Form 222 84 FR 51368, Sept. 30, 2019.
2 21

E:FRFM20JYR1.SGM

20JYR1